SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-16-088046
Filing Date
2016-03-15
Accepted
2016-03-15 11:17:01
Documents
71
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v432940_10k.htm 10-K 822932
2 EXHIBIT 23.1 v432940_ex23-1.htm EX-23.1 2673
3 EXHIBIT 31.1 v432940_ex31-1.htm EX-31.1 10047
4 EXHIBIT 32.1 v432940_ex32-1.htm EX-32.1 4646
5 GRAPHIC tpg22.jpg GRAPHIC 29224
  Complete submission text file 0001144204-16-088046.txt   5381791

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ttnp-20151231.xml EX-101.INS 1174635
7 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20151231.xsd EX-101.SCH 57170
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20151231_cal.xml EX-101.CAL 37049
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20151231_def.xml EX-101.DEF 295151
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20151231_lab.xml EX-101.LAB 378390
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20151231_pre.xml EX-101.PRE 351011
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13341 | Film No.: 161505978
SIC: 2836 Biological Products, (No Diagnostic Substances)